미국의 플라스미드 정제 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 등급별, 용도별, 최종 용도별, 부문별 예측(2025-2033년)

U.S. Plasmid Purification Market Trends:

The U.S. plasmid purification market size was estimated at USD 699.4 million in 2024 and is projected to reach USD 1.84 billion by 2033, growing at a CAGR of 11.41% from 2025 to 2033. This growth is driven by increasing demand for gene therapy, vaccine development, and biopharmaceutical research, where high-quality plasmid DNA is critical.

U.S. Plasmid Purification Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. plasmid purification market based on product & service, grade, application, and end use:

• Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
• Products
  • Instruments
  • Kits & Reagents
• Services
• Grade Outlook (Revenue, USD Million, 2021 - 2033)
• Molecular Grade
• Transfection Grade
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cloning & Protein Expression
• Transfection & Gene Editing
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service Segment
  • 1.2.2. Grade Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use Segment
• 1.3. Information Analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data Validation & Publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. U.S. Plasmid Purification Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Vaccine development (especially DNA vaccines)
    • 3.2.1.2. Rise in biopharmaceutical R&D
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Ethical constraints related to the use of rDNA technology
• 3.3. U.S. Plasmid Purification Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Plasmid Purification Market: Product & Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Plasmid Purification Market Product & Service Movement Analysis
• 4.3. U.S. Plasmid Purification Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
• 4.4. Products
  • 4.4.1. Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Instruments
    • 4.4.2.1. Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Kits & Reagents
    • 4.4.3.1. Kits & reagents market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Services
  • 4.5.1. Services market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Plasmid Purification Market: Grade Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Plasmid Purification Market Grade Movement Analysis
• 5.3. U.S. Plasmid Purification Market Size & Trend Analysis, by Grade, 2021 to 2033 (USD Million)
• 5.4. Molecular Grade
  • 5.4.1. Molecular-grade market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Transfection Grade
  • 5.5.1. Transfection grade market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Plasmid Purification Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Plasmid Purification Market Application Movement Analysis
• 6.3. U.S. Plasmid Purification Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Cloning & Protein Expression
  • 6.4.1. Cloning & protein expression market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Transfection & Gene Editing
  • 6.5.1. Transfection & gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Plasmid Purification Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Plasmid Purification Market End Use Movement Analysis
• 7.3. U.S. Plasmid Purification Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Academic & Research Institutes
  • 7.5.1. Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Contract Research Organizations
  • 7.6.1. Contract research organizations market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Merck KGaA
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product/Service benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. QIAGEN
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product/Service benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Thermo Fisher Scientific, Inc.
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product/Service benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Takara Bio
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product/Service benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Promega Corporation
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product/Service benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Zymo Research
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product/Service benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. MP BIOMEDICALS
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product/Service benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. New England Biolabs
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product/Service benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. MCLAB
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product/Service benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Applied Biological Materials, Inc.
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product/Service benchmarking
    • 8.4.10.4. Strategic initiatives